Ceftobiprole: a potential empirical post-operative monotherapy in prosthetic joint infections

Ceftobiprole: a potential empirical post-operative monotherapy in prosthetic joint infections

Abstract Background This study aimed to evaluate in vitro susceptibility to ceftobiprole of clinical strains identified from prosthetic joint infections (PJIs) compared to that of the associations currently recommended for post-operative empirical antibiotic therapy (PEAT) (vancomycin with either ce...

Full description

Bibliographic Details
Main Authors:	Claire Duployez, Frédéric Wallet, Henri Migaud, Eric Senneville, Caroline Loiez
Format:	Article
Language:	English
Published:	BMC 2020-03-01
Series:	Annals of Clinical Microbiology and Antimicrobials
Subjects:	Prosthetic joint infection Ceftobiprole Empirical antibiotic therapy Bacterial resistance
Online Access:	http://link.springer.com/article/10.1186/s12941-020-00351-5

Similar Items

Ceftobiprole for the treatment of infective endocarditis: A case series
by: Carlo Tascini, et al.
Published: (2020-03-01)

Susceptibility of ceftobiprole against Gram-positive and Gram-negative clinical isolates from 2019 from different European territories
by: Stephen Hawser, et al.
Published: (2022-06-01)

Surveillance of ceftobiprole against Gram-positive and Gram-negative clinical isolates from 2018 from different European territories
by: Stephen Hawser, et al.
Published: (2021-09-01)

Ceftobiprole Perspective: Current and Potential Future Indications
by: Tommaso Lupia, et al.
Published: (2021-02-01)

Evaluation of the in vitro activity of ceftobiprole against clinical isolates of Staphylococcus aureus
by: Carola Mauri, et al.
Published: (2016-12-01)

In Vitro Activity of Tedizolid, Dalbavancin, and Ceftobiprole Against Clostridium difficile
by: Dana Binyamin, et al.
Published: (2018-06-01)

Ceftobiprole for Treatment of MRSA Blood Stream Infection: A Case Series
by: Mahmoud E, et al.
Published: (2020-08-01)

Real-life experience with ceftobiprole in a tertiary-care hospital
by: Emanuele Durante-Mangoni, et al.
Published: (2020-09-01)

Compassionate Use of Cefiderocol to Treat a Case of Prosthetic Joint Infection Due to Extensively Drug-Resistant <i>Enterobacter hormaechei</i>
by: Soline Siméon, et al.
Published: (2020-08-01)

Prosthetic joint infection: state-of-the-art
by: Boris Sergeyevich Belov
Published: (2013-12-01)

Ceftobiprole medocaril: clinical and pharmacological characteristics and possibilities of clinical use
by: Rachina S.A., et al.
Published: (2024-09-01)

Population Pharmacokinetic and Pharmacodynamic Analysis for Maximizing the Effectiveness of Ceftobiprole in the Treatment of Severe Methicillin-Resistant Staphylococcal Infections
by: Pier Giorgio Cojutti, et al.
Published: (2023-12-01)

Cefto Real-Life Study: Real-World Data on the Use of Ceftobiprole in a Multicenter Spanish Cohort
by: Carmen Hidalgo-Tenorio, et al.
Published: (2023-07-01)

Joint Prosthetic Infection: UpDate Approaches to Diagnosis and Treatment
by: B. S. Belov, et al.
Published: (2020-05-01)

BACTERIAL (SEPTIC) ARTHRITIS AND PROSTHETIC JOINT INFECTION
by: B. S. Belov, et al.
Published: (2017-04-01)

Susceptibility to ceftobiprole of respiratory-tract pathogens collected in the United Kingdom and Ireland during 2014–2015
by: Santerre Henriksen A, et al.
Published: (2018-08-01)

Ceft-to-Ceft Study: Real-Life Experience with Ceftaroline and Ceftobiprole in Treatment of the Principal Infectious Syndromes in a Spanish Multicenter Hospital Cohort
by: Daniel Arnés García, et al.
Published: (2023-12-01)

Real-World Experience of Ceftobiprole for Community- and Hospital-Acquired Pneumonia from a Stewardship Perspective
by: Silvia Corcione, et al.
Published: (2024-04-01)

A case report of treatment of a streptococcal brain abscess with ceftobiprole supported by the measurement of drug levels in the cerebrospinal fluid
by: Simone Giuliano, et al.
Published: (2024-03-01)

Suppressive Antibiotic Treatment in Prosthetic Joint Infections: A Perspective
by: Javier Cobo, et al.
Published: (2021-06-01)

Real-life experience with ceftobiprole in Canada: Results from the CLEAR (CanadianLEadership onAntimicrobialReal-life usage) registry
by: George G. Zhanel, et al.
Published: (2021-03-01)

In Vitro Antibacterial Activity of Ceftobiprole and Comparator Compounds against Nation-Wide Bloodstream Isolates and Different Sequence Types of MRSA
by: Lingqin Li, et al.
Published: (2024-02-01)

Evaluation of ampicillin plus ceftobiprole combination therapy in treating Enterococcus faecalis infective endocarditis and bloodstream infection
by: Simone Giuliano, et al.
Published: (2025-01-01)

Unveiling the Relationship between Ceftobiprole and High-Molecular-Mass (HMM) Penicillin-Binding Proteins (PBPs) in <i>Enterococcus faecalis</i>
by: Paola Conti, et al.
Published: (2024-01-01)

Ampicillin and Ceftobiprole Combination for the Treatment of <i>Enterococcus faecalis</i> Invasive Infections: “The Times They Are A-Changin”
by: Simone Giuliano, et al.
Published: (2023-05-01)

Culturing Periprosthetic Tissues in BacT/Alert® Virtuo Blood Culture Bottles for a Short Duration of Post-operative Empirical Antibiotic Therapy
by: C. Duployez, et al.
Published: (2020-05-01)

Ceftobiprole Medocaril Is an Effective Post-Exposure Treatment in the Fischer 344 Rat Model of Pneumonic Tularemia
by: Mark M. Hahn, et al.
Published: (2023-08-01)

Do Prosthetic Joint Infections Worsen the Functional Ambulatory Outcome of Patients with Joint Replacements? A Retrospective Matched Cohort Study
by: Isabel Mur, et al.
Published: (2020-12-01)

Impact of PBP4 Alterations on β-Lactam Resistance and Ceftobiprole Non-Susceptibility Among Enterococcus faecalis Clinical Isolates
by: Lorenzo M. Lazzaro, et al.
Published: (2022-01-01)

Tolerance of Prolonged Oral Tedizolid for Prosthetic Joint Infections: Results of a Multicentre Prospective Study
by: Eric Senneville, et al.
Published: (2020-12-01)

Dalbavancin treatment for prosthetic joint infections in real-life: a national cohort study and literature review
by: Morgan Matt, et al.
Published: (2021-06-01)

CLASSIFICATION AND ALGORITHM FOR DIAGNOSIS AND TREATMENT OF HIP PROSTHETIC JOINT INFECTION
by: T. Winkler, et al.
Published: (2016-06-01)

Prosthetic joint infections: update in diagnosis and treatment
by: Swiss Medical Weekly
Published: (2005-05-01)

In Vitro Activities of Ceftobiprole, Dalbavancin, Tedizolid and Comparators against Clinical Isolates of Methicillin-Resistant <i>Staphylococcus aureus</i> Associated with Skin and Soft Tissue Infections
by: Sofia Maraki, et al.
Published: (2023-05-01)

Histoplasma capsulatum prosthetic joint infection
by: Sandra Rajme-López, et al.
Published: (2023-06-01)

Ototoxicity associated with extended dalbavancin treatment for a shoulder prosthetic joint infection
by: Anna Lange, et al.
Published: (2023-10-01)

Can metagenomic next-generation sequencing identify the pathogens responsible for culture-negative prosthetic joint infection?
by: Chaoxin Wang, et al.
Published: (2020-03-01)

Bone allograft impregnated with tobramycin and vancomycin delivers antibiotics in high concentrations for prophylaxis against bacteria commonly associated with prosthetic joint infections
by: Björn Berglund, et al.
Published: (2024-12-01)

Dalbavancin for the Treatment of Prosthetic Joint Infections: A Narrative Review
by: Luis Buzón-Martín, et al.
Published: (2021-05-01)

Successful treatment of a prosthetic hip infection due to Enterococcus faecalis with sequential dosing of oritavancin and prosthesis preservation without prosthetic joint surgical manipulation
by: Jullian P. Nguyen, et al.
Published: (2020-01-01)